Senior Manager, Customs and Trade, EMEAI at Bristol-Myers Squibb

Dublin, County Dublin, Ireland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Undergraduate degree in Business, Finance, Supply Chain or International Trade, preferred
A minimum 5 years Supply Chain/Finance/Logistics experience in a bio-pharmaceutical company
At least 3 years in a Trade Compliance role
A clear understanding of regional/global Customs regulations regarding importing and exporting (as required) in the commercial and research environments
Sound experience (inferred from context)

Responsibilities

Support the management of efficient importation and exportation of all BMS materials for EMEAI
Implement and monitor compliance with all BMS and EU/national Customs & Trade [C&T] import and export requirements, to ensure uninterrupted supply of all materials within EMEAI
Collaborate with BMS functions (Transportation, Tax, Finance, Markets etc.) and third parties to ensure timely physical movements, customs release and onward supply of BMS materials and medicines in EMEAI
Support the timely development and application of Customs Procedures, Tariff classifications and Import authorizations for Commercial, Clinical & Cell Therapy materials
Provide oversight of all required documentation to ensure accurate and complete documents are available for presentation to Customs
Gather, assess and interpret data to monitor and evaluate the performance of Customs brokers. Work with Importing sites to manage BMS Customs brokers
Maintain awareness of import and export Regulatory changes and work with all stakeholders to communicate and update business requirements for uninterrupted supply
Support Regional/local Customs & Trade Planning and integration into company activities designed to mitigate or defer duty and associated costs
Initiate and support where appropriate company participation and partnership in Supply Chain Security and Import Compliance Programs (i.e., AEO)
Support Import and other Customs Compliance related audits
Ensure all Customs related records are appropriate and maintained in accordance with BMS and Legal requirements
Support other Global Logistics Services (GLS) activities as and when required
Work with EMEAI C&T Lead as and when required to support C&T activities in EMEAI
Develop and deliver training as required

Skills

Customs Compliance

Trade Compliance

Importation

Exportation

EU Regulations

Supply Chain Management

Cell Therapy Operations

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free